Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : WDC/Sandisk Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Win-Lose-Draw who wrote (19074)	2/12/2001 10:23:50 AM
From: Gary Martin	Respond to of 60323

Hi All, I read a short column in the recent edition of "Money" magazine touting the prospects(and low p/e ratio)for Sandisk. Is the bottom in (relatively speaking) for the stock? When one evaluates the current earnings and the expected growth rate for its market segment, the stock may be a nice long term speculation? Sorry to come into the chat so late, but the stock came up on my wife's low P/E value stock search as well....so I had to ask. Gary

To: Win-Lose-Draw who wrote (19074)	2/12/2001 10:35:32 AM
From: Art Bechhoefer	Respond to of 60323

W-L-D, see my response in message #19075. As to the price of Merck and Exxon-Mobil, both these stocks are well above their levels earlier in the year. The pharmaceuticals have as a group done better over the last year than almost any other sector. Certain drug stock prices are influenced by company-specific problems, such as a patent on a key drug running out (Merck, AstraZeneca, Glaxo-SmithKline) or a patent being reaffirmed (Johnson & Johnson, Amgen). Oil stocks, particularly those which are mainly producers, rather than refiners and marketers, are up anywhere from 50 to 100 percent in the last year and will remain high so long as crude oil and natural gas prices remain at current levels. Art